These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1355491)

  • 1. Neurological consequences of immune dysfunction: lessons from HIV infection and multiple sclerosis.
    Wiley CA; Johnson RT; Reingold SC
    J Neuroimmunol; 1992 Sep; 40(1):115-9. PubMed ID: 1355491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia in diseases of the central nervous system.
    Nelson PT; Soma LA; Lavi E
    Ann Med; 2002; 34(7-8):491-500. PubMed ID: 12553488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood-central nervous system barriers actively control immune cell entry into the central nervous system.
    Engelhardt B
    Curr Pharm Des; 2008; 14(16):1555-65. PubMed ID: 18673197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central nervous system lesions in the early stages of HIV infection].
    Wingertsmann L; Chrétien F; Authier FJ; Paraire F; Durigon M; Gray F
    Arch Anat Cytol Pathol; 1997; 45(2-3):106-17. PubMed ID: 9382601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.
    Trebst C; Sørensen TL; Kivisäkk P; Cathcart MK; Hesselgesser J; Horuk R; Sellebjerg F; Lassmann H; Ransohoff RM
    Am J Pathol; 2001 Nov; 159(5):1701-10. PubMed ID: 11696431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MiRNAs: new actors in the physiopathology of multiple sclerosis].
    Jagot F; Davoust N
    Med Sci (Paris); 2017; 33(6-7):620-628. PubMed ID: 28990564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of integrins in immune-mediated diseases of the nervous system.
    Archelos JJ; Previtali SC; Hartung HP
    Trends Neurosci; 1999 Jan; 22(1):30-8. PubMed ID: 10088997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?
    Hohlfeld R
    J Neurol Sci; 2008 Feb; 265(1-2):93-6. PubMed ID: 17459415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.
    Waschbisch A; Schröder S; Schraudner D; Sammet L; Weksler B; Melms A; Pfeifenbring S; Stadelmann C; Schwab S; Linker RA
    J Immunol; 2016 Feb; 196(4):1558-67. PubMed ID: 26746191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine expression in the brain during the acquired immunodeficiency syndrome.
    Tyor WR; Glass JD; Griffin JW; Becker PS; McArthur JC; Bezman L; Griffin DE
    Ann Neurol; 1992 Apr; 31(4):349-60. PubMed ID: 1586135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropathogenesis of HIV-1 infection.
    Gendelman HE; Lipton SA; Tardieu M; Bukrinsky MI; Nottet HS
    J Leukoc Biol; 1994 Sep; 56(3):389-98. PubMed ID: 8083614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in multiple sclerosis: Central and peripheral mode of action.
    Ohl K; Tenbrock K; Kipp M
    Exp Neurol; 2016 Mar; 277():58-67. PubMed ID: 26626971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature, nurture, and microbes: The development of multiple sclerosis.
    Wekerle H
    Acta Neurol Scand; 2017 Nov; 136 Suppl 201():22-25. PubMed ID: 29068487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease.
    Dickson DW; Lee SC; Mattiace LA; Yen SH; Brosnan C
    Glia; 1993 Jan; 7(1):75-83. PubMed ID: 8423065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: lessons from molecular neuropathology.
    Lassmann H
    Exp Neurol; 2014 Dec; 262 Pt A():2-7. PubMed ID: 24342027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possible role of prolactin in the immunopathogenesis of multiple sclerosis.
    Draca S; Lević Z
    Med Hypotheses; 1996 Aug; 47(2):89-92. PubMed ID: 8869921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system.
    't Hart BA; Amor S
    Curr Opin Neurol; 2003 Jun; 16(3):375-83. PubMed ID: 12858076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry of human immunodeficiency virus in the central nervous system and an hypothesis concerning the pathogenesis of AIDS meningoencephalomyelitis.
    Rhodes RH; Ward JM
    Prog AIDS Pathol; 1989; 1():167-79. PubMed ID: 2491241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.